Literature DB >> 3363493

Assessment by dipyridamole-thallium-201 myocardial scintigraphy of coronary risk before peripheral vascular surgery.

R N Sachs1, P Tellier, P Larmignat, J Azorin, L Fischbein, B Beaudet, P Cadilhac, M Cupa, G De Saint Florent, M Vulpillat.   

Abstract

From October 1983 to January 1985, 46 patients (38 men and 8 women; average age, 60 years; range, 37 to 83 years) underwent peripheral vascular surgery of either the internal carotid artery or the arteries of the lower limbs. Each patient had a thorough clinical examination, an ECG, and a dipyridamole-thallium-201 myocardial scan before operation. On the basis of results, they were divided into two groups: 20 patients with and 26 patients without chronic ischemic heart disease. Three major cardiac events were noted during or after a period of 1 month after surgery: There were two deaths due to cardiac ischemic events and one patient had postoperative unstable angina pectoris. These three patients were classified in the coronary group (NS). When the patients were classified on the basis of whether or not there was thallium redistribution on serial images after infusion of dipyridamole, 14 with redistribution and 32 without redistribution were noted. The three patients who had major cardiac events were in the former group (p less than 0.04). Our data suggest that patients in whom redistribution occurs have a high incidence of postoperative ischemic events. These patients should be considered for particular preoperative coronary care to avoid major postoperative cardiac events and to increase chances of survival.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3363493

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

Review 1.  Advances in nuclear cardiology: preoperative risk stratification.

Authors:  Kenneth A Brown
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

2.  Preoperative and long-term cardiac risk assessment. Predictive value of 23 clinical descriptors, 7 multivariate scoring systems, and quantitative dipyridamole imaging in 360 patients.

Authors:  J Lette; D Waters; H Bernier; P Champagne; J Lassonde; M Picard; M Cerino; S Nattel; Y Boucher; F Heyen
Journal:  Ann Surg       Date:  1992-08       Impact factor: 12.969

Review 3.  Perioperative care of the vascular surgery patient: the perspective of the internist.

Authors:  R Granieri; D S Macpherson
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

4.  A comparison of maximal exercise and dipyridamole thallium-201 planar gated scintigraphy.

Authors:  W Martin; A C Tweddel; G Main; I Hutton
Journal:  Eur J Nucl Med       Date:  1992

Review 5.  The question: to test or not to test in preoperative cardiac risk evaluation.

Authors:  J A Leppo; S T Dahlberg
Journal:  J Nucl Cardiol       Date:  1998 May-Jun       Impact factor: 5.952

6.  Preoperative cardiac risk assessment for noncardiac surgery.

Authors:  J A Leppo
Journal:  J Nucl Cardiol       Date:  1995 Sep-Oct       Impact factor: 5.952

Review 7.  Prognostic value of myocardial perfusion imaging: state of the art and new developments.

Authors:  K A Brown
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

8.  Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events.

Authors:  D D Miller; H G Stratmann; L Shaw; B R Tamesis; M D Wittry; L T Younis; B R Chaitman
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

9.  A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery.

Authors:  M D Kertai; E Boersma; J J Bax; M H Heijenbrok-Kal; M G M Hunink; G J L'talien; J R T C Roelandt; H van Urk; D Poldermans
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

10.  Postoperative myocardial infarction and cardiac death. Predictive value of dipyridamole-thallium imaging and five clinical scoring systems based on multifactorial analysis.

Authors:  J Lette; D Waters; J Lassonde; S Dubé; F Heyen; M Picard; M Morin
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.